Abstract
Aim:This study aimed to explore the clinical efficacy of probiotics plus quadruple therapy on Serum levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), C-reactive protein (CRP), gastrin (GAS) and motilin (MTL) in treating Helicobacter pylori (Hp)-positive gastric ulcer (GU).
Methods:One hundred and twenty-four patients with Hp-positive GU treated in our hospital from January 2021 to January 2024 were randomly separated into control group and observation group. The former received conventional quadruple therapy, and the latter received tetralogy of viable bifidobacterium tablets combined with conventional quadruple therapy. The clinical efficacy, Hp eradication rate, levels of inflammatory cytokines and gastrointestinal hormone, incidence of adverse reactions along with quality of life were compared in 2 groups.
Results:The total effective rate of the observation group was 96.77%, higher than that of the control group (82.25%). The Hp eradication rate in the observation group was higher than the control group. After therapy, IL-6, TNF-α and CRP levels were declined in 2 groups, and those in the observation group presented lower as comparing with the control group. After therapy, MLT level was elevated while GAS level was declined in 2 groups, and the improvements of MLT and GAS levels in the observation group were more significant as comparing with the control group. The incidence of diarrhea in the observation group was lower than that in the control group, and there was no difference in the incidence of nausea and abdominal distension between 2 groups.
Conclusion:After therapy, physiological function, physical function, emotional function, body pain, general health, mental health, vitality and social function scores were elevated in 2 groups, and those in the observation group presented higher as comparing with the control group. Probiotics combined with quadruple therapy is effective and safe in the treatment of Hp-positive GU, which can promote the Hp eradication rate, improve the inflammation response and gastrointestinal hormone levels, maintain the balance of intestinal flora and promote the quality of life of patients.
Keywords
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.